Mubadala Capital to take CI Financial private in $8.1bn deal

BY Richard Summerfield

Mubadala Capital has announced it is to take CI Financial private in an $8.66bn, all-cash deal, including debt.

The deal, which is subject to court approval, regulatory clearances and other customary closing conditions, is expected to close in the second quarter of 2025. The transaction is not subject to any financing conditions.

Under the terms of the deal, Mubadala Capital, the asset management subsidiary of the Abu Dhabi state investment fund, has agreed to pay C$32 a share for CI Financial, representing a 33 percent premium to its closing price last Friday.

“This transaction, with its significant cash premium, represents an exceptional outcome for CI shareholders and provides certainty to shareholders while CI pursues its ongoing transformation,” said William E. Butt, lead director and chair of the special committee at CI. “It also provides significant benefits to Canada, by providing long-term capital to underpin the building of a Canadian champion in the wealth and asset management industries.”

“Mubadala Capital invests with a long-term outlook and represents long-term capital – providing stability and certainty for CIʼs clients and employees,” said Kurt MacAlpine, chief executive of CI. “With this transaction, CI has never been better positioned to fulfil our mission of delivering outstanding services and solutions to our clients.”

“We are fully aligned with the strategy and direction of the firm and look forward to working with the CI management team to continue to build this outstanding business and ensure that CI continues to deliver superior services to its clients,” said Hani Barhoush, managing director and chief executive of Mubadala Capital.

“We look forward to partnering with CI’s talented team to capitalize on new opportunities in the asset and wealth management sectors and build on the company’s successes,” said Oscar Fahlgren, chief investment officer at Mubadala Capital.

The transaction also supports CI’s expansion in the US, where it operates as Corient and will continue to operate independently under the Corient brand.

“We’re excited to continue to execute our US strategy with our incredibly talented team,” said Mr MacAlpine. “Notably, the transaction preserves Corient’s structure and its unique private partnership model, under which 250 of our colleagues are equity partners in Corient. Our partnership model is highly differentiated in our industry – it allows us to deliver the best of the firm to all clients and creates a culture of collaboration and unified purpose.”

The deal assigns the Toronto-based investment manager, which has more than C$500bn in assets and a long history of managing money for wealthy US and Canadian investors, an equity value of C$4.7bn ($3.36bn), or an enterprise value of C$12.1bn when including its debt.

The takeover marks Mubadala Capital’s largest acquisition to date. The firm, which recently raised a $3.1bn private equity fund, will rely on a large equity investment by its parent company to finance a takeover commitment that is larger than its entire fund.

News: Mubadala to take Canada's CI Financial private in about $8.7 billion deal

Blackstone acquires Jersey Mike’s in $8bn deal

BY Fraser Tennant

In a deal that underscores private equity’s (PE’s) increasing interest in franchise operators, alternative asset manager Blackstone is to acquire a majority ownership of sandwich chain Jersey Mike’s Subs for $8bn, including debt.

The acquisition – the financial terms of which have not been disclosed – is intended to help enable Jersey Mike’s accelerate its expansion across and beyond the US market, as well as aid its ongoing technological investments.

Jersey Mike’s is the latest in Blackstone’s investment in food franchises in 2024. In February, it announced an equity investment in 7 Brew Coffee, while April saw an agreement to buy Tropical Smoothie Cafe from PE firm Levine Leichtman Capital Partners.

“Jersey Mike’s has grown for more than half a century by maintaining an unrelenting focus on quality – consistently building on its loyal customer base as it has scaled nationwide,” said Peter Wallace, a senior managing director at Blackstone. “Blackstone has deep experience helping accelerate the expansion of high-growth franchise businesses and this area is one of our highest-conviction investment themes.”

Blackstone’s investment ends Jersey Mike’s almost seven decades as a privately owned business, in which time it has grown to become the second-largest sandwich chain in the US, behind Subway. Peter Cancro, who has been with Jersey Mike’s since 1971 and owned it since 1975, will remain chief executive and maintain a “significant” stake, according to Blackstone.

“We believe we are still in the early innings of Jersey Mike’s growth story and that Blackstone is the right partner to help us reach even greater heights,” said Mr Cancro. “Blackstone has helped drive the success of some of the most iconic franchise businesses globally and we look forward to working with them to help make significant new investments going forward.” 

The transaction is expected to be completed in early 2025 subject to the satisfaction of certain closing conditions, including applicable regulatory approvals.

Mr Wallace concluded: “Our capital and resources will help support key investments in growth and technology for the benefit of Jersey Mike’s customers and exceptional franchisees.”

News: Blackstone strikes $8 billion deal for sandwich chain Jersey Mike’s Subs

Cencora acquires RCA in $4.6bn transaction

BY Fraser Tennant

In a deal that expands its speciality services, drug distributor Cencora is to acquire Retina Consultants of America (RCA) from private equity firm Webster Equity Partners for $4.6bn.

The acquisition of RCA – a management services organisation (MSO) that operates a network of retina specialists – will add to Cencora’s specialty capabilities and expand its business, broadening physician and manufacturer relationships as well as Cencora’s value proposition to all its stakeholders.

Cencora plans to fund the transaction through a combination of existing cash on hand and new debt financing. RCA’s affiliated practices, physicians and management will retain a minority interest in RCA, with Cencora holding approximately 85 percent ownership in RCA upon closing.

“The acquisition of RCA will allow Cencora to broaden our relationships with community providers in a high growth segment and build on our leadership in specialty,” said Bob Mauch, president and chief executive of Cencora. “With a compelling value proposition for physicians, an impressive leadership team and strong clinical research capabilities, RCA is well-positioned at the forefront of retinal care.

The leading MSO in the retina space and a trusted healthcare provider, RCA’s nearly 300 retina specialists across 23 states provide high-quality care to patients with physicians conducting over 2 million visits annually.

Cencora expects to use its suite of manufacturer services to enhance RCA’s research programme and outcomes, maintaining its position as a partner of choice to pharmaceutical innovators in the retina space.

“We are pleased to enter our next phase of growth with the support of a leading global pharmaceutical solutions organisation,” said Robby Grabow, chief executive of RCA. “With additional resources to support the continued execution of our growth strategy, we will be better positioned to continue expanding our physician network and enhancing the quality of care we provide.”

The transaction is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals.

Mr Mauch concluded: “The addition of RCA will allow us to expand our MSO solutions and drive differentiated value across the healthcare system for manufacturers, providers and patients.”

News: Cencora bolsters specialty business with $4.6 bln deal for Retina Consultants of America

Sanofi to sell Opella to CD&R in €16bn deal

BY Fraser Tennant

In a transaction with an enterprise value of €16bn, French drugmaker Sanofi is to sell a 50 percent controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice (CD&R).

CD&R’s acquisition of Opella paves the way for the creation of a new, standalone leader in consumer healthcare, while supporting Sanofi’s strategy and increased focus on innovative medicines and vaccines.

French public investment bank Bpifrance is expected to become a minority shareholder, taking a stake of around 2 percent and a seat on the board of Opella.

“This is an exciting opportunity for CD&R to partner with Sanofi, one of the world’s leading healthcare companies,” said Eric Rouzier, partner and head of European Healthcare at CD&R. “Opella is differentiated by the quality of its brand portfolio and its highly skilled and motivated workforce.”

Headquartered in France, Opella employs over 11,000 people and operates in 100 countries with 13 manufacturing sites and four science and innovation development centres. With a portfolio of iconic brands, such as Allegra, Doliprane and Dulcolax, Opella is the third-largest business worldwide in the over-the-counter and vitamins, minerals and supplements market, serving more than half a billion consumers worldwide.

“This acquisition is a major and exciting milestone in Opella's journey,” said Julie Van Ongevalle, president and chief executive of Opella. “Partnering with CD&R will allow Opella to unlock its full development potential, to further drive value creation and deploy the exceptional talent of our teams to become a leading company in the fast-moving consumer healthcare space.”

The transaction, which is expected to close in Q2 2025 at the earliest, is subject to finalisation of definitive agreements, completion of the appropriate social processes and customary statutory approvals.

“We are proud of what Opella and its inspired people have already accomplished and are confident that the future will be even brighter,” concluded Mr Hudson. “We share the love and emotional attachment to Opella’s brands, hence our decision to remain vested in its future.”

News: Sanofi reaches deal on terms of sale of consumer health arm, say French government sources

EQT and others acquire Nord Anglia Education in $14.5bn deal

BY Richard Summerfield

Swedish private equity firm EQT, Neuberger Berman Private Markets and the Canada Pension Plan (CPP) Investment Board have agreed to acquire international schools operator Nord Anglia Education in a deal worth $14.5bn including debt.

The deal will see the EQT-led consortium acquire a majority stake in Nord Anglia, which operates over 80 schools in 33 countries and educates more than 85,000 students worldwide.

Existing owners EQT and CPP Investments will remain shareholders in the company through a new fund investment and reinvestment, respectively, the firms noted in a statement announcing the deal. Nord Anglia’s relationship with EQT began with the firm’s initial investment in 2008. In 2017, EQT strengthened its commitment by increasing its stake in the company and welcoming CPP Investments as a partner. EQT is investing in Nord Anglia through its BPEA Private Equity Fund VIII.

“Nord Anglia’s extensive track record and unwavering commitment to supporting over 85,000 students worldwide uniquely positions the company for future growth,” said David Stonberg, managing director at Neuberger Berman. “We are honored to lead a consortium of investors who share our passion for delivering exceptional educational experiences.”

“We are excited to partner with the EQT team, whose deep industry expertise and proven collaboration with Nord Anglia’s management enhance this investment,” added Jonathan Shofet, managing director at Neuberger Berman. “Together with CPP Investments, we aim to support Nord Anglia’s mission of delivering world-class education.”

“EQT has had the privilege of partnering with Nord Anglia since 2008, and we’ve developed a deep connection with this exceptional business,” said Jack Hennessy, a partner within the advisory team at EQT. “Over the years, we’ve witnessed Nord Anglia grow from six schools to more than 80 which today serve more than 85,000 students across the globe. Alongside this growth, we’re proud to have helped elevate teaching excellence through industry-leading partnerships established under our ownership. With today’s announcement, we are thrilled to continue this journey with Neuberger Berman, CPP Investments, and our global institutional co-investors, and support Nord Anglia’s continued success and innovation in the global education space.”

“Nord Anglia was CPP Investments’ first direct equity investment in the private education sector, and we are proud to have been a partner, alongside EQT, in its growth globally over the years,” said Caitlin Gubbels, senior managing director & global head of private equity at CPP Investments. “Our reinvestment allows us to remain committed to Nord Anglia while delivering an attractive return to the CPP Fund. We are highly confident in the growth potential of the sector and look forward to working with new investors.”

“Families choose our schools because we help our students gain the academic outcomes, confidence, and life skills they need to succeed in the future,” said Andrew Fitzmaurice, chief executive of Nord Anglia Education. “At the heart of our students’ achievements are our high-quality teachers. Our ability to attract and develop outstanding teachers sees us receive over 60 applications for every teaching vacancy, reflecting the strength of our world-class professional learning program and career pathways.”

He continued: “Since day one, EQT and CPP Investments have shared our educational philosophy and with the addition of Neuberger Berman, we are further strengthening this successful partnership. Focused on improving students’ outcomes, we will accelerate our research of new teaching and learning practices, curricula innovation, and the growth and development of our global teaching community.”

News: Sweden’s EQT, others to take control of Nord Anglia for $14.5 billion